HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Urokinase therapy in mesenteric venous thrombosis: a case study.

Abstract
Mesenteric venous thrombosis is an emergency usually treated by bowel resection with an end-to-end anastomosis and in some cases anticoagulant therapy. The survival rate is low. The literature records many cases of mesenteric venous thrombosis and various treatment modalities. An 18-year-old man was successfully treated for mesenteric venous thrombosis by the placement of a femoral infusion catheter in the superior mesenteric artery for continuous infusion of urokinase (Abbot Laboratories, N. Chicago, Ill.). This case study and overview of the disease process reviews the nursing implications of this problem.
AuthorsM A Crouch
JournalJournal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing (J Vasc Nurs) Vol. 11 Issue 4 Pg. 99-103 (Dec 1993) ISSN: 1062-0303 [Print] United States
PMID8286284 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Urokinase-Type Plasminogen Activator
Topics
  • Adolescent
  • Angiography
  • Humans
  • Male
  • Mesenteric Vascular Occlusion (diagnostic imaging, drug therapy, nursing)
  • Mesenteric Veins
  • Patient Care Planning
  • Urokinase-Type Plasminogen Activator (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: